---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-007369"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2024-06-05T23:59:59+00:00"
generated_at: "2026-06-01T06:20:44.927576+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Dermata regains Nasdaq minimum bid price compliance; delisting risk resolved

## Summary
- Received Nasdaq notice on June 4, 2024 that company is in compliance with $1.00 minimum bid price requirement.
- Previously failed to comply in Nov 2023 and received a 180-day extension through Nov 11, 2024.
- Compliance regained ahead of extension deadline; matter closed.

## SEC filing metadata
- accession: 0001654954-24-007369
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2024-06-05T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495424007369/0001654954-24-007369-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495424007369/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-007369
- JSON: https://secwatch.observer/filing/0001654954-24-007369.json
- Plain text: https://secwatch.observer/filing/0001654954-24-007369.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.